You are here
Tabula Rasa HealthCare to Participate in Institute for Healthcare Improvement Conference: Creating Age-Friendly Health Systems
MOORESTOWN, N.J., Sept. 21, 2018 (GLOBE NEWSWIRE) -- CareKinesis, a subsidiary of Tabula Rasa HealthCare (NASDAQ:TRHC), has been invited to join the Institute for Healthcare Improvement (IHI) at its conference focused on creating Age-Friendly Health Systems. The conference will take place in Boston, MA, September 20 – 21, 2018.
Presenting at the IHI conference on behalf of TRHC subsidiary CareKinesis will be Senior Vice President for Total Quality Management Carlos F. Perez, MSN, RN-BC. Mr. Perez oversees system processes to meet client expectations and supports the evaluation and implementation of performance improvement and innovation. He guides clinical teams in the application of evidence-based practice models, instituting policies and procedures to help standardize the practice of clinicians to improve healthcare outcomes for patients.
Age–Friendly Health Systems is an initiative of The John A. Hartford Foundation and the IHI in partnership with the American Hospital Association (AHA) and the Catholic Health Association of the U.S. (CHA). According to the IHI, the goal of the initiative is to develop an Age-Friendly Health Systems framework, which can be rapidly spread to 20% of U.S. hospital systems by the year 2020.
The premise of this System is that an age-friendly framework will measurably improve the quality of care for older adults and optimize value for health systems. The age-friendly 4M framework (What Matters, Medication, Mentation, Mobility) developed by five prototyping health systems in 2017, is both evidence-based and able to be put into practice reliably in health care settings.
Similarly, TRHC’s CareKinesis was founded in 2009 with a focus on medication safety, especially for the elderly on multiple medications, and operates under the premise that medication risk can be identified and mitigated.
Medication treatment is the most common medical intervention. Its imprecise use represents the fourth leading cause of death and contributes to an estimated 45 to 50 million adverse drug events (ADEs) annually. TRHC products and services are built around a proprietary Medication Risk Mitigation Matrix® and cloud-based software applications which enable optimization of a patient’s medication regimen by combining clinical and pharmacology data, population-based algorithms and extensive patient-genomic information to deliver “precision medicine”.
According to Perez, and the focus of his “storyboard presentation” at the IHI conference, “The ROI for our clients has included a reduction in falls, hospital admissions, re-admissions, and length of stay. I look forward to discussing with conference attendees, in a unique 'open forum' format, their challenges and their successes in serving our older population of Americans.”
Recently, TRHC launched the first science-based total Medication Risk Score™ that helps clinicians assess which participants are at highest risk for drug-related problems and require medication management attention. The scoring today is being used in a large-scale CMS innovation model.
Prescribers, pharmacists and healthcare payer organizations now have access to sophisticated and innovative tools to better identify the medication-related needs of patients.
About Tabula Rasa HealthCare
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com. Follow us on Twitter @TabulaRasaHC for up-to-date information, or for information about CareKinesis, visit www.carekinesis.com.
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 14, 2018, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website http://ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.
Bob East or Asher Dewhurst